The future of brain circuit-targeted therapeutics

被引:20
|
作者
Siddiqi, Shan H. [1 ,2 ]
Khosravani, Sanaz [1 ,3 ]
Rolston, John D. [1 ,4 ]
Fox, Michael D. [1 ,3 ]
机构
[1] Brigham & Womens Hosp, Ctr Brain Circuit Therapeut, Boston, MA 02115 USA
[2] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA
[3] Harvard Med Sch, Dept Neurol, Boston, MA USA
[4] Harvard Med Sch, Dept Neurosurg, Boston, MA USA
关键词
TRANSCRANIAL MAGNETIC STIMULATION; POSTTRAUMATIC-STRESS-DISORDER; CORTICAL EXCITABILITY; THETA-BURST; FUNCTIONAL CONNECTIVITY; BRIEF EXPOSURE; DEPRESSION; NETWORKS; RTMS; TMS;
D O I
10.1038/s41386-023-01670-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The principle of targeting brain circuits has drawn increasing attention with the growth of brain stimulation treatments such as transcranial magnetic stimulation (TMS), deep brain stimulation (DBS), and focused ultrasound (FUS). Each of these techniques can effectively treat different neuropsychiatric disorders, but treating any given disorder depends on choosing the right treatment target. Here, we propose a three-phase framework for identifying and modulating these targets. There are multiple approaches to identifying a target, including correlative neuroimaging, retrospective optimization based on existing stimulation sites, and lesion localization. These techniques can then be optimized using personalized neuroimaging, physiological monitoring, and engagement of a specific brain state using pharmacological or psychological interventions. Finally, a specific stimulation modality or combination of modalities can be chosen after considering the advantages and tradeoffs of each. While there is preliminary literature to support different components of this framework, there are still many unanswered questions. This presents an opportunity for the future growth of research and clinical care in brain circuit therapeutics.
引用
收藏
页码:179 / 188
页数:10
相关论文
共 50 条
  • [31] Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future
    Chen, Ricky
    Cohen, Adam L.
    Colman, Howard
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (08)
  • [32] The future of heart failure with preserved ejection fraction Deep phenotyping for targeted therapeutics
    Heinzel, Frank R.
    Shah, Sanjiv J.
    HERZ, 2022, 47 (04) : 308 - 323
  • [33] The future of targeted therapeutics in oncology: Targets to find, early and long term treatments
    Blay, Jean-Yves
    M S-MEDECINE SCIENCES, 2007, 23 (12): : 1073 - 1074
  • [34] Integrin Targeted Therapeutics
    Millard, Melissa
    Odde, Srinivas
    Neamati, Nouri
    THERANOSTICS, 2011, 1 : 154 - 188
  • [35] Targeted Cancer Therapeutics
    Hait, William N.
    CANCER RESEARCH, 2009, 69 (04) : 1263 - 1267
  • [36] Targeted therapeutics in melanoma
    Z Ali
    R Fisher
    J Larkin
    British Journal of Cancer, 2012, 107 (9) : 1663 - 1663
  • [37] Mapping the dysfunctome provides an avenue for targeted brain circuit therapy
    Hollunder, Barbara
    Horn, Andreas
    NATURE NEUROSCIENCE, 2024, 27 (03) : 401 - 402
  • [39] Targeted Therapeutics in Oncology and Neurology: Advances in Kinase Inhibition and Biomarkers for Brain Injury
    Kargbo, Robert B.
    ACS MEDICINAL CHEMISTRY LETTERS, 2024, 16 (01): : 29 - 31
  • [40] Future therapeutics
    Harel-Bellan, Anniek
    BIOFUTUR, 2013, (340) : 47 - 48